No abstract available
Kastritis E., Terpos E., Symeonidis A., Labropoulou V., Delimpasi S., Mancuso K., et al. (2023). Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study. AMERICAN JOURNAL OF HEMATOLOGY, 98(9), E226-E229 [10.1002/ajh.27001].
Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study
Mancuso K.;Zamagni E.;
2023
Abstract
No abstract availableFile in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
